Gritstone bio, Inc. (OTC: GRTSQ), a clinical-stage biotechnology company working to develop the world's most potent vaccines, ...

Preclinical data has suggested that the combination therapy could potentially optimise outcomes for patients with recurrent ...

Infinitopes' lead vaccine candidate ITOP1 is a novel, precision targeted, immunologically durable, off-the-shelf c ...

Infinitopes' lead vaccine candidate ITOP1 is a novel, precision targeted, immunologically durable, "off-the-shelf" cancer vaccine, designed to save lives by preventing disease recurrence in first-line ...

In the first study, titled "The Anti-tumor Response of BPM31510 is Associated with Immune Cell Regulation in the Tumor Microenvironment," researchers showed that BPM31510 significantly increases ...